U-Blot® Research Grade JMB2002/Ab2001.08Cat. No. WA3028$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade JMB2002/Ab2001.08Cat. No. WA3028
U-Blot® Research Grade IzuralimabCat. No. WA3027
U-Blot® Research Grade IzenivetmabCat. No. WA3026
U-Blot® Research Grade IzeltabartCat. No. WA3025
U-Blot® Research Grade IzastobartCat. No. WA3024
U-Blot® Research Grade IzalontamabCat. No. WA3023
U-Blot® Research Grade ixotatugCat. No. WA3022
U-Blot® Research Grade IxekizumabCat. No. WA3021
U-Blot® Research Grade IvuxolimabCat. No. WA3020
U-Blot® Research Grade IvonescimabCat. No. WA3019
U-Blot® Research Grade IvicentamabCat. No. WA3018
U-Blot® Research Grade ItolizumabCat. No. WA3017